Genomic landscape surveys of breast cancer cohorts found BRCA1 and TP53 somatic mutations were more common in younger women at 20–40 years of age compared to older women at >65 years despite the increased mutational somatic load in older patients [16]. The gene discussed is TP53; the disease is breast carcinoma.